Research Article
Bacitracin for Injection Recall: Impact on Immediate Breast Implant Surgical Outcomes
Table 8
Outcomes by patient and surgical factors.
| | | Complication | | | Yes | No | value |
| | Any complication (n = 25) | | Age | 54.64 ± 13.35 | 51.56 ± 12.10 | 0.234 | | BMI | 27.96 ± 5.92 | 25.99 ± 4.78 | 0.059 | | CCI | 1.60 ± 0.87 | 1.48 ± 1.01 | 0.555 | | Smoking history | | | | | Never smoker | 16 (64.00) | 169 (74.45) | <0.001 | | Former smoker | 6 (24.00) | 57 (25.11) | | | Current smoker | 3 (12.00) | 1 (0.44) | | | History of breast radiation therapy | 8 (32.00) | 33 (14.54) | 0.025 | | History of capsular contracture | 5 (20.00) | 25 (11.01) | 0.188 | | Prior prosthetic device | | | | | Tissue expander | 6 (24.00) | 62 (27.31) | 0.053 | | Implant | 9 (36.00) | 121 (53.30) | | | None | 10 (40.00) | 44 (19.38) | | | Surgery type | | | | | Augmentation | 0 (0.00) | 17 (7.49) | 0.157 | | Reconstruction | 25 (100.00) | 210 (92.51) | | | Total surgical time | 186.96 ± 97.68 | 124.25 ± 58.96 | <0.001 | | Implant volume | 498.20 ± 140.76 | 441.78 ± 142.94 | 0.062 | | Implant surgical plane | | | | | Pre-Pectoral | 24 (96.00) | 205 (90.31) | 0.348 | | Retro-pectoral | 1 (4.00) | 22 (9.69) | | | Use of acellular dermal matrix | 17 (68.00) | 124 (54.63) | 0.201 | | Number of antibiotics | 2.44 ± 0.65 | 2.57 ± 0.57 | 0.294 | | Povidone-iodine 10% | 20 (80.00) | 194 (95.46) | 0.469 | | Infection (n = 18) | | Age | 54.58 ± 14.93 | 51.62 ± 11.98 | 0.322 | | BMI | 28.48 ± 6.04 | 25.96 ± 4.81 | 0.037 | | CCI | 1.56 ± 0.86 | 1.47 ± 1.01 | 0.728 | | Smoking history | | | | | Never smoker | 10 (55.56) | 177 (75.00) | <0.001 | | Former smoker | 5 (27.78) | 58 (24.58) | | | Current smoker | 3 (16.67) | 1 (0.42) | | | History of breast radiation therapy | 5 (27.78) | 36 (15.25) | 0.164 | | History of capsular contracture | 2 (1.11) | 30 (12.71) | 0.844 | | Prior prosthetic device | | | | | Tissue expander | 4 (22.22) | 64 (27.12) | 0.007 | | Implant | 5 (27.78) | 127 (53.81) | | | None | 9 (50.00) | 45 (19.07) | | | Surgery type | | | | | Augmentation | 0 (0.00) | 17 (7.20) | 0.238 | | Reconstruction | 18 (100.00) | 219 (92.80) | | | Total surgical time | 174.72 ± 87.97 | 126.70 ± 63.18 | 0.003 | | Implant volume | 510.56 ± 120.26 | 443.43 ± 143.87 | 0.055 | | Implant surgical plane | | | | | Pre-pectoral | 17 (94.44) | 214 (90.68) | 0.591 | | Retro-pectoral | 1 (5.56) | 22 (9.32) | | | Use of acellular dermal matrix | 12 (66.67) | 129 (54.66) | 0.323 | | Number of antibiotics | 2.33 ± 0.69 | 2.57 ± 0.57 | 0.098 | | Povidone-iodine 10% | 14 (37.84) | 202 (93.09) | 0.370 | | Cellulitis (n = 9) | | Age | 52.94 ± 13.35 | 51.79 ± 12.18 | 0.781 | | BMI | 23.85 ± 2.64 | 26.22 ± 4.99 | 0.157 | | CCI | 1.33 ± 1.00 | 1.48 ± 1.00 | 0.663 | | Smoking history | | | | | Never smoker | 6 (66.67) | 181 (73.88) | 0.786 | | Former smoker | 3 (33.33) | 60 (24.49) | | | Current smoker | 0 (0.00) | 4 (1.63) | | | History of breast radiation therapy | 3 (33.33) | 38 (15.51) | 0.153 | | History of capsular contracture | 2 (22.22) | 30 (12.24) | 0.376 | | Prior prosthetic device | | | | | Tissue expander | 1 (1.11) | 67 (27.35) | 0.191 | | Implant | 4 (4.44) | 128 (52.24) | | | None | 4 (4.44) | 50 (20.41) | | | Surgery type | | | | | Augmentation | 0 (0.00) | 17 (6.94) | 0.413 | | Reconstruction | 9 (100.00) | 228 (93.06) | | | Total surgical time | 173.67 ± 85.31 | 128.51 ± 65.05 | 0.044 | | Implant volume | 477.78 ± 155.85 | 447.10 ± 142.91 | 0.529 | | Implant surgical plane | | | | | Pre-pectoral | 9 (100.00) | 222 (90.61) | 0.335 | | Retro-pectoral | 0 (0.00) | 23 (9.39) | | | Use of acellular dermal matrix | 5 (55.56) | 136 (55.51) | 0.998 | | Number of antibiotics | 2.56 ± 0.53 | 2.55 ± 0.58 | 0.982 | | Povidone-iodine 10% | 8 (88.89) | 208 (84.90) | 0.742 |
|
|
BMI: body mass index, CCI: Charlson comorbidity index. Bold values indicate statistical significance.
|
